Metraipolis › archive › dc_5f68e83c8a09

Case Report: Zinc deficiency as a modifiable risk factor for enfortumab vedotin-induced cutaneous adverse events — Europe PMC PMID:41395599

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41395599
DOI
10.3389/fonc.2025.1690770
License (as archived)
solo-consultazione
Archived
2026-11-08T04:43:44.107Z
SHA-256 of the archived text
9b41fb506c269841b6fb8749139c2f97c785c258b04cf4dd811e170be9e57b4c
Stable URL of this page
https://metraipolis.com/documento/dc_5f68e83c8a09

How to cite

Case Report: Zinc deficiency as a modifiable risk factor for enfortumab vedotin-induced cutaneous adverse events — Europe PMC PMID:41395599 — Europe PMC (en), https://europepmc.org/article/MED/41395599 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5f68e83c8a09 (Metraipolis archive dc_5f68e83c8a09, sha256 9b41fb506c269841b6fb8749139c2f97c785c258b04cf4dd811e170be9e57b4c)
BibTeX
@misc{dc5f68e83c8a09,
  title = {Case Report: Zinc deficiency as a modifiable risk factor for enfortumab vedotin-induced cutaneous adverse events — Europe PMC PMID:41395599},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41395599},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5f68e83c8a09; sha256 9b41fb506c269841b6fb8749139c2f97c785c258b04cf4dd811e170be9e57b4c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41395599. Agents can read the archived copy with the MCP tool read_document.